Global Platelet Aggregation Device Market Insights Forecasts to 2032

• The Global Platelet Aggregation Device Market Size was valued at USD 5.2 Billion in 2022.
• The Market is growing at a CAGR of 6.5% from 2022 to 2032
• The Worldwide Platelet Aggregation Device Market is expected to reach USD 8.5 billion by 2032
•  Asia Pacific is expected to grow the fastest during the forecast period

 

Get more details on this report -

Request Free Sample PDF

The Global Platelet Aggregation Device Market Size is expected to reach USD 8.5 billion by 2032, at a CAGR of 8.5% during the forecast period 2022 to 2032.

 

Venipuncture is performed as part of the platelet aggregation test in a non-clotting medium that is created during the plasma extraction procedure using centrifugation. Aggregometers are also utilised in this process. The process of platelet aggregation involves a number of medical devices that offer precise control over the active blood flow, which in turn limits the amount to which platelet thrombus formation occurs. Aggregometers, platelet collection systems, platelet function centrifuges, and platelet function analyzers are a few examples of platelet aggregation equipment.

 

Impact Of COVID 19 On Global Platelet Aggregation Device Market

The COVID 19 pandemic has led a significant impact on the global platelet aggregation device market and there has been substantial proofs that SARS-CoV-2 infections is related with atheothrombotic phenomena. An article published by NCBI in July 2021 stated that the occurrence of thrombocytopenia is a critical condition in SARS-CoV-2 infection which may hamper the respiratory symptoms but also increasing the risk of mortality and is prognostic factor related to  platelet in COVID 19. The rise in the research based on the platelet aggregation process on human platelet cells involved in the COVID 19 has resulted into the massive impact on the growth of the market over the forecast period. Apart from this, the demand for platelet aggregation devices is anticipated to remain the same after the pandemic which is fuelling the market growth.

 

Key Market Drivers

The rise in the number of cardiovascular issues, Malaria, Dengue, HIV, leukamia has resulted a huge demand for the platelet function testing. As per the Center for Disease and Control (CDC), Dengue is considered as an epidemic is over 100 countries in Americas, APAC, African as well as the Caribbean nations. On an average, around 75 million dengue infections occur every year across the world. It is also estimated that about 200 million people were impacted with malaria across the world in the year 2017. The risk of malaria is high in tropical, sub tropical, and poor areas across the globe. There are estimated 35 to 40 million HIV-positive individuals worldwide as of 2017, and 40% of those individuals are undiagnosed. In order to diagnose these disorders, platelet function tests are becoming more and more popular. Around 35 to 40 million people are suffering from HIV in the world among which 40% of people remain undiagnosed. Thus, there is an increasing demand for platelet function tests for diagnosis of such health issues.

 

Apart from this heart ailments is again another cause of death in American nations. As per the CDC, each year 6,10,000 people lose their lives due to heart issues in the U.S. Coronary heart disease has caused 3,70,000 deaths per year in the U.S. About 7,35,000 people from American nations get heart attack every year among which 5,25,000 people get first heart attack and 2,10,000 get recurrent heart attack. Hence, anti platelet therapy is commonly used procedure in order to reduce the risk of major cardiovascular events in people suffering from cardiovascular issues. The high residual reactivity of platelets in patients undergoing anti platelet therapies leds to thrombo embolic complications.

 

Key Market Challenges

Apart from many driving factors, the global platelet aggregation device market has many challenges. The high cost of devices, lack of skilled and well trained professionals, and procedural limitations limit the growth of the market. The specialized platelet aggregometers are very expensive which range from USD 10,000 to USD 20,000 on the basis of their features. This rate will further increase by adding associated reagents, accessories and consumable expenses. Thus, it is very difficult for small to mid level hospitals and diagnostic centers to afford it.

 

Market Segmentation

 

Product Insights

Reagents segment holds the highest market share over the forecast period

On the basis of product, the global platelet aggregation device market is bifurcated into systems, reagents, and consumables and reagents. Among these, the reagents segment holds the highest market share over the forecast period. On the other hand, this dominance is affected by the rising use of automated analyzers. Platelet aggregation devices mainly comprises platelet function centrifuges (PFC), flow cytometry platelet function analyzers, and aggregometers. There are different types of aggregometers on the basis of variations in methodologies like impedance whole blood aggregometry, lumi-aggregometry, light transmission aggregometry, and flow cytometry. Among all these, LTA is high used method used to assess platelet function. It is used to monitor platelet function disorders and antiplatelet therapies.

 

There has also been significant increase in the number of speciality laboratories and hospitals in the developing economies. The rise in the investment made in healthcare infrastructure is also leading in the use of aggregation systems in hospitals and laboratories. Due to the growing number of research studies to understand the mechanisms underlying platelet interaction with vascular surfaces, as well as the evaluation and screening of anti-thrombotic factors to identify new targets for anti-platelet drugs, there is an increase in the demand for platelet aggregation systems in both academic institutions and pharmaceutical companies.

 

End Use Insights

Standalone hospitals segment is dominating the market with the largest market share

Based on the end use, the global platelet aggregation devices market is segmented into standalone hospitals, diagnostic laboratories, blood banks, research and academic institutes, and others. Among these, standalone hospitals segment is dominating the market with the largest market share. The growth is attributed to the increasing number of hospitals in developing countries, increasing private and public investments for development as well as advancement of healthcare infrastructure, increasing use of platelet function tests in the evaluation pre and post operative hemostasis and in transfusion medicine.

Screening tests like visco elastometry is developed in order to determine the strength of a blood clot in the clinical laboratories in hospitals. Apart from this, the rising awareness about the benefits of platelet function tests as well as technological advancements of platelet aggregation devices by the healthcare professionals, increasing use of advanced platelet aggregation devices by the hospitals, increasing number of surgical procedures are propelling the demand of such devices in hospitals.

 

Regional Insights

North America is dominating the market with the largest market share over the forecast period

 

Get more details on this report -

Request Free Sample PDF

North America is dominating the market with the largest market share over the forecast period due to the rise in elderly population, rise in target disorders, technological developments in platelet aggregation metres, and growing understanding among medical professionals of the advantages of platelet aggregation testing in disease detection. According to estimates from the United States Centres for Disease Control (CDC) that were updated in 2021, an American may get a heart attack every 40 seconds. Additionally, according to the World Federation of Haemophilia 2021 report, there were approximately 14,816 haemophiliacs in the United States in 2021, including 11,790 cases of haemophilia A and 3,026 cases of haemophilia B. In Canada, there were 3,924 haemophiliacs in 2021, including 3,223 cases of haemophilia A and 701 cases of haemophilia B. As a result of the accurate disease identification, the high incidence of various chronic and blood ailments in this region is predicted to increase demand for platelet aggregation devices.

 

Asia Pacific, on the other hand is witnessing the fastest market growth over the forecast period due to the increasing number of pediatric population along with rising risks of targeted diseases, increasing demand for platelet screening programs for diagnosis of HIV and other health issues like Malaria and Dengue in the region.

 

Recent Market Developments

• In May 2019, Haemonetics has got the FDA approval for the use of TEG 6s Hemostasis Analyzer System in adult trauma setting for cardiology procedures and cardiovascular surgery.

 

List of Key Companies

• F. Hoffmann La-Roche Ltd.
• Siemens AG
• Haemonetics Corporation,
• Sysmex Corporation
• Helena Laboratories Corporation
• Accriva Diagnostics
• Aggredyne, Inc
• Bio/Data Corporation

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global Platelet Aggregation Device Market based on the below-mentioned segments:

 

Platelet Aggregation Device Market, Product Analysis

• Systems
• Reagents
• Consumables and reagents

Platelet Aggregation Device Market, End Use Analysis

• Standalone Hospitals
• Diagnostic laboratories
• Blood banks
• Research and academic institutes
• Others

  

Platelet Aggregation Device Market, Regional Analysis

·       North America

o   US

o   Canada

o   Mexico

·          Europe

o   Germany

o   Uk

o   France

o   Italy

o   Spain

o   Russia

o   Rest of Europe

·          Asia Pacific

o   China

o   Japan

o   India

o   South Korea

o   Australia

o   Rest of Asia Pacific

·          South America

o   Brazil

o   Argentina

o   Rest of South America

·          Middle East & Africa

o   UAE

o   Saudi Arabia

o   Qatar

o   South Africa

o   Rest of Middle East & Africa